The Ethics Of Genetic Commerce Rob Quail by Rob Quail 9780470692547, 9781405166980, 0470692545, 1405166983 instant download after payment.
Our rapidly expanding genetic knowledge today points toward a near future in which the elements of humanity closest to our moral core may themselves be produced, manipulated, commodified, and exchanged.
- Explores the moral and ethical concerns derived from an increasing knowledge of genetics and the variety of its commercial applications
- A major contribution to the emerging understanding of the role that ethics will play in genetic commerce
- Written by experts from the academic and corporate sector, with diverse backgrounds in business, social science, and philosophy
- Addresses a range of relevant issues, including genetic screening, the use of individual’s genetic information, the rise of genetically modified foods, patenting, pharmaceutical mergers and monopolization, and the implications of genetic testing on non-human mammals
Content:
Chapter 1 Is a Genetics Screening Program for Job Applicants Ethical? An Analysis of the Conditions Necessary for Requiring Genetic Screenings in the Hiring Process (pages 3–24): Thomas Harter
Chapter 2 The Business Ethics of Genetic Screening (pages 25–41): Duane Windsor
Chapter 3 Genetic Commerce: The Challenges for Human Resource Management (pages 42–54): Karen S. Markel and Lizabeth A. Barclay
Chapter 4 Geneticize Me! The Case for Direct?to?Consumer Genetic Testing (pages 55–69): Ronald Munson
Chapter 5 Proscription, Prescription, or Market Process? Comments on Genetic Screening (pages 70–83): Eugene Heath
Chapter 6 Transgenic Organisms, the European Union, and the World Trade Organization (pages 87–108): Dennis Cooley
Chapter 7 Commercialization of the Agrarian Ideal and Arguments Against the New “Green Revolution”: Feeding the World with “Frankenfoods”? (pages 109–126): Johann A. Klaassen
Chapter 8 Corporate Decisions About Labeling Genetically Modified Foods (pages 127–138): Chris MacDonald and Melissa Whellams
Chapter 9 Moral Imagination, Stakeholder Engagement, and Genetically Modified Organisms (pages 139–142): Denis G. Arnold
Chapter 10 Who Owns My Ideas About Your Body? (pages 145–176): Asher Meir
Chapter 11 Pharmaceutical Mergers and Genetic Technology: A Problematic Combination (pages 177–189): Michael Potts
Chapter 12 Stakeholder Care Theory: The Case of Genetic Engineering and Non?Human Mammals (pages 190–207): Jamie R. Hendry
Chapter 13 Unresolved Issues and Further Questions: Meir, Potts, and Hendry (pages 208–213): Laura Hartman
